Coming Soon

In the wake of the Supreme Court ruling last week that invalidated patents on isolated gene sequences held by Myriad Genetics, a number of companies are jumping in to offer BRCA1 and BRCA2 testing. Pharmacogenomics Reporter notes that Ambry Genetics, GeneDx, Gene by Gene, Pathway Genomics, and the University of Washington have said that they will be launching BRCA gene tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.